Aggressive breast tumors possess heterogeneity that impacts successful diagnosis and treatment. Mapping this complexity with imaging biomarkers of different biologic specificity supports patient-specific management. We compare biomarkers from diffusion-weighted MRI (intravoxel incoherent motion (IVIM)) and 18F-fluorodeoxyglucose (FDG) PET (dynamic pharmacokinetic modeling) in 10 breast cancer patients in a simultaneous PET/MR system. Voxelwise correlations were performed to study intralesion relationships between biomarkers. Intralesion correlations were observed, such as between PET plasma transfer rate K1 and tissue diffusivity Dt, that also showed potential diagnostic value in tumor classification. This feasibility study establishes a workflow that enables more detailed investigation in larger cohorts.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords